Skip Navigation

Cardiovascular Research 1998 37(3):676-683; doi:10.1016/S0008-6363(97)00251-4
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Klabunde, R. E
Right arrow Articles by Weiss, H. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klabunde, R. E
Right arrow Articles by Weiss, H. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts

Richard E Klabundea,*, James Tseb and Harvey R Weissb

aDeborah Research Institute, 20 Pine Mill Road, Brown Mills, NJ 08015, USA
bUMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08855, USA

* Corresponding author. Tel. (+1-609) 893 1016; Fax (+1-609) 893 2441.

Objective: Several studies have shown that increasing cGMP in the heart reduces contractility, however, decreasing basal cGMP levels have also been shown in some studies to reduce contractility. This study was designed to evaluate the hypothesis that decreasing basal levels of cGMP decreases ventricular contractility, and that this depressed function is associated with a decrease in cAMP. Methods: Using paced, constant flow, buffer-perfused rat hearts, we determined the effects of intracoronary infusions of the guanylyl cyclase inhibitor, LY83583 (10–5 M), on ventricular function, oxygen consumption, and ventricular content of cGMP and cAMP. These experiments were conducted in the absence and presence of isoproterenol (ISO) to increase baseline left ventricular developed pressure (LVDP) and cAMP. Results: LY83583, infused for 25 min, decreased LVDP by 44±3 (SE), 77±20 and 120±38 mmHg, in control, 10–9 M, and 10–8 M ISO-stimulated hearts, respectively. Regardless of the level of ISO stimulation, LY83583 reduced LVDP to the same sub-basal level. Oxygen consumption also decreased, but proportionately less than LVDP. ISO increased cAMP without changing cGMP. LY83583 decreased cGMP by about 25% at all levels of ISO, and decreased cAMP by 22% in the 10–8 M ISO-stimulated group. Conclusion: Guanylyl cyclase inhibition by LY83583 decreased cGMP, cAMP and ventricular contractility. However, LY83583 depression of contractility was not always associated with a reduction in cAMP, suggesting that LY83583 can depress contractility by both cAMP-dependent and independent mechanisms.

KEYWORDS Myocardial; Cyclic nucleotides; Nitric oxide; Oxygen consumption; LY-83583; Rat


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Biol Res NursHome page
M. Antosova, A. Strapkova, and T. Turcan
Exogenous Irritant-Induced Airway Hyperreactivity and Inhibition of Soluble Guanylyl Cyclase
Biol Res Nurs, October 1, 2008; 10(2): 93 - 101.
[Abstract] [PDF]


Home page
J. Physiol.Home page
A. Godecke, T. Heinicke, A. Kamkin, I. Kiseleva, R. H Strasser, U. K M Decking, T. Stumpe, G. Isenberg, and J. Schrader
Inotropic response to {beta}-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts
J. Physiol., April 1, 2001; 532(1): 195 - 204.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.